B of A Securities Downgrades Doximity, Inc. to Sell
B of A Securities set a new sell rating and a $20 price target for Doximity, Inc, a 3.57% downside from the current price.
Key Points
- On June 29, 2026, B of A Securities downgraded Doximity, Inc. (NYSE:DOCS) to a sell rating with a $20 price target.
- B of A Securities's $20 price target implies 3.57% downside from Doximity, Inc.'s ($DOCS) current $20.74 share price.
- Doximity shares traded at $20.88 on Monday, with a market cap of about $3.82 billion and a P/E ratio of 21.3.
- Insider activities included multiple transactions by Interim PAO Siddharth Sitaram, while analysts have mixed ratings on the stock.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 29, 2026, B of A Securities analyst Allen Lutz downgraded Doximity, Inc. (NYSE:DOCS) to a sell rating, setting a new price target of $20. This change comes as the stock traded around $20.88 on Monday.
B of A Securities vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Doximity, Inc. Stock Down 22.4%
Shares of NYSE:DOCS traded near $20.88 on Monday. Doximity, Inc. has a market cap of approximately $3.82 billion, a P/E ratio of 21.3, and a forward P/E of 13.1. The stock has seen a 52-week low of $17.15 and a high of $76.51. Its 50-day moving average is $22.11, while the 200-day moving average stands at $39.57. The company's financial health is reflected in its current ratio of 6.09 and a quick ratio of 5.81.
$DOCS price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Recent Earnings
Doximity reported revenue of $644.9 million, growing by 5.1% year-over-year. The net margin stands at 30.4%, with a return on equity of 19.3%. The next earnings report is expected on August 6, 2026.
Insider Buying and Selling at Doximity, Inc.
Insider transactions at Doximity included several by Interim PAO Siddharth Sitaram on June 8, 2026. Sitaram both bought and sold 5,000 shares on that day, with some transactions planned under Rule 10b5-1. President Steven Zatz also acquired 55,524 shares on May 15, 2026.
Analysts Set New Price Targets
On June 29, 2026, B of A Securities downgraded Doximity to a sell rating with a $20 price target. Previously, Barclays downgraded the stock to hold with the same target on May 15, 2026. Leerink Partners maintained a buy rating with a $25 target on May 14, 2026. The consensus among 19 analysts is a buy rating, with a mean target price of $25.32.
About Doximity, Inc.
Doximity, Inc., headquartered in San Francisco, operates a digital platform for medical professionals in the U.S. The platform provides a personalized newsfeed with clinical and professional content and offers tools like a HIPAA-compliant AI assistant and telehealth services. Led by CEO Jeffrey A. Tangney, the company serves healthcare providers and systems.
Bottom Line
B of A Securities' downgrade to a sell rating for Doximity, Inc. reflects a cautious outlook with a new price target of $20. Investors keep a close eye on analyst ratings and insider activities for indications of company health. It's important to remember that analyst ratings and price targets are subject to change and should be considered as part of a broader investment strategy.
Get Doximity, Inc. alerts
New 13F filings, insider trades, and analyst moves on $DOCS, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.